The Africa Centres for Disease Control and Prevention has launched a new four-year programme aimed at strengthening antibiotic resistance testing and laboratory systems across Africa, with Ethiopia among eight participating countries.
The initiative, launched in Addis Ababa this week, brings together the African Society for Laboratory Medicine and the European Union under a project known as Advancing Regional Integrated Laboratory Capacity for AMR Control, or ARILAC.
The programme targets antimicrobial resistance, commonly known as AMR, a growing global health threat in which infections become resistant to antibiotics and other treatments.
Ethiopia, alongside Cameroon, Chad, Gabon, Mozambique, Sierra Leone, Uganda and Zimbabwe, will take part in the project over the next 48 months.
The initiative aims to improve microbiology laboratory systems, disease surveillance and testing capacity through investments in laboratory equipment, data systems, genomic surveillance and workforce training across human and animal health sectors.
Africa CDC said the project comes at a time when large parts of Africa still lack adequate laboratory testing capacity for drug-resistant infections.
A joint assessment by Africa CDC and ASLM found that only 1.3 percent of more than 50,000 medical laboratories assessed across 14 African countries currently conduct routine testing for priority AMR pathogens.
According to the findings, more than 261 million people in those countries do not have access to AMR testing services.
“Without targeted investment, this gap is expected to widen as populations grow,” said Yenew Kebede (MD), Acting Director of the Centre for Laboratory Diagnostics and Systems at Africa CDC.
He said only 20 percent of laboratories currently use automated systems for pathogen identification and antimicrobial susceptibility testing, limiting timely diagnosis and evidence-based treatment.
Under the programme, participating countries will receive support to strengthen laboratory quality systems, improve access to modern testing technologies and expand regional surveillance networks.
The project will also support laboratory assessments, updated surveillance guidelines, mentorship programmes and regional quality assurance systems, according to ASLM chief executive Nqobile Ndlovu.
Mesay Hailu (MD), Director General of the Ethiopian Public Health Institute, said the programme would support implementation of national action plans on antimicrobial resistance and reaffirmed Ethiopia’s commitment to the initiative.
European Union officials said the programme is intended to strengthen long-term health security systems across the continent through improved laboratory and surveillance capacity.
The launch meeting, held from May 6 to May 7 at Africa CDC headquarters in Addis Ababa, brought together representatives from public health institutes, veterinary and clinical laboratories, surveillance systems and development partners to coordinate implementation plans for the project.
